Health Canada approves Aflivu, a biosimilar for retinal diseases, enhancing treatment options and affordability for Canadian ...

The VISTA trial is evaluating and comparing 2 dose levels of laru-zova to an untreated control group for the treatment of ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Arshad Khanani, MD, MA, FASRS, discussed the upcoming Clinical Trials Summit (CTS) 2025 meeting, which has become a key event in the ophthalmology and retina research calendar. This fifth-year ...

Key Takeaways Retinal vessel tortuosity is significantly higher in patients with diabetic retinopathy, indicating early vascular changes. Lower fractal dimension values in DR patients suggest less ...

As researchers continue to explore the retina as a window into systemic health, fluorescence lifetime imaging ophthalmoscopy (FLIO) offers a novel and underexplored dimension, according to Aaron Y.